Pleura - Mesothelioma

JANS Article

Extended Pleurectomy Decortication and Chemotherapy Versus Chemotherapy Alone for Pleural Mesothelioma (MARS 2): A Phase 3 Randomized Controlled Trial

June 20, 2024 | Jason Trevis

In this phase three national, multicenter, UK randomized controlled trial, the authors seek to compare outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone. The trial recruited patients between 2015 and 2021 from 26...

Video

Objective Discrepancies in the MARS-2 Trial: An Interview with David Waller

December 6, 2023 | David Waller…

At the 2023 EACTS Annual Meeting, CTSNet Editor in Chief Joel Dunning and CTSNet senior editors set out to interview the most knowledgeable CT surgeons from around the world. Stay...

Video

Laser Assisted Extended Pleurectomy Decortication for Malignant Pleural Mesothelioma

October 25, 2023 | Apostolos Nakas…

Malignant pleural mesothelioma is an aggressive tumor of the pleura. Extended pleurectomy and decortication is a lung sparing cytoreductive procedure used in the management of this disease for curative intent....

JANS Article

Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival

January 12, 2023 | Cameron LindSilver Contributor

A recent study found that mesothelioma patients who undergo both lung-sparing extended pleurectomy and decortication can achieve extended survival compared to those who undergo just one type of surgery. When...

JANS Article

In Global News: Prevalence of Spin in RCT Reports, Setting the Standard for Teamwork, and the Continued Public Health Challenge of Asbestos

May 24, 2019 | Claire Vernon

Patient Care and General Interest Despite being the leading cause of death in the US, heart disease was the most-Googled disease in only one state: Maine. A study that sought...

JANS Article

Revised Modified RECIST Criteria in Malignant Pleural Mesothelioma (Version 1.1): A Step Forward in a Long Race

July 27, 2018 | Aristotle ProtopapasGold Commentor

A useful editorial debating current issues on the classification of mesothelioma.

...
Video

Mesothelioma and Lobectomy: An Interview With Raja Flores

July 19, 2018 | Joel DunningGold ContributorSilver Commentor…

Filmed at the 2018 STS Annual Meeting in Ft Lauderdale, FL, Joel Dunning of the James Cook University Hospital in London, UK, interviews Raja Flores of the Mount Sinai School...

Video

Surgery for Mesothelioma in the MARS II Era

February 1, 2018 | Apostolos Nakas

Apostolos Nakas of the Glenfield Hospital in Leicester, UK, presents an overview of the surgical treatment of mesothelioma. Dr Nakas focuses on extended pleurectomy decortication, which is being evaluated in...

JANS Article

Pathologists Face Their “Deep Blue” Moment

December 13, 2017 | Mark FergusonBronze Contributor

As many will recall, world chess champion Garry Kasparov was defeated by IBM’s Deep Blue computer in 1997. Now machine-learning algorithms have bested trained pathologists in differentiating between benign and...

JANS Article

Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma

October 31, 2017 | Mark FergusonBronze Contributor

In this single institution study, the prognostic role of soluble mesothelin-related peptides (SMRP) was evaluated in patients with pleural mesothelioma. Preoperative levels of SMRP were related to tumor volume and...

JANS Article

National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma

October 24, 2017 | Mark FergusonBronze Contributor

From one of the few relatively unbiased sources of information regarding surgical treatment of pleural mesothelioma, the authors describe populations of patients undergoing EPP or P/D and their outcomes. Survival...

JANS Article

Debulking Surgery and Hyperthermic Chemotherapy for Pleural Mesothelioma: A Pilot Study

September 20, 2017 | Marco NardiniBronze Contributor

We urgently need more answers for the patients affected by mesothelioma, a devastating diasese whose prognosis is 6-9 months from the diagnosis. We are now living the era of plateau...

Video

Mesothelioma Debate: Surgery Offers the Best Outcome

March 24, 2017 | Paul Van Schil

Paul Van Schil of Antwerp University Hospital, Antwerp, Belgium, argues that surgery offers the best outcome for patients with mesothelioma. Dr. Van Schil reviews the evidence from surgical trials, noting...

LOAD MORE
ADVERTISE ON CTSNET